OVERVIEW

Sermorelin is a synthetic peptide and a growth hormone–releasing hormone (GHRH) analog that stimulates the pituitary gland to secrete growth hormone naturally. By mimicking the body’s own GHRH, Sermorelin promotes a pulsatile and physiologic release of growth hormone, which is essential for maintaining muscle mass, bone density, metabolism, and overall tissue repair. Unlike direct growth hormone therapy, Sermorelin encourages the body to regulate hormone levels naturally, reducing the risk of overstimulation or adverse effects associated with exogenous growth hormone administration. It has been studied in both clinical and research settings for its potential in addressing age-related growth hormone decline, improving recovery, and supporting general metabolic health.

Sermorelin is typically supplied as a lyophilized powder for research or experimental use and requires reconstitution before administration. Preclinical and clinical studies suggest it may help improve lean muscle mass, enhance recovery from injuries, support better sleep, and assist in fat metabolism. Side effects are usually mild but may include injection site irritation, headaches, or temporary flushing. Sermorelin is not widely approved by major regulatory authorities for general medical use and is primarily used in experimental or research contexts. Professional medical guidance is strongly recommended for dosing, administration, and monitoring, especially in individuals with underlying hormonal or metabolic conditions.